"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.
Impact
If enacted, the bill will introduce stringent penalties for various offenses related to kratom. Manufacturing, distributing, or possessing kratom in amounts of one ounce or more would be classified as a second-degree crime, punishable by 5 to 10 years of imprisonment and significant fines. Lesser offenses for quantities under one ounce would be deemed as third or fourth-degree crimes with correspondingly lighter penalties. This move reflects a shift toward a more stringent regulatory framework regarding drug substances, thereby aligning state law with federal recommendations to mitigate public health risks associated with kratom.
Summary
Assembly Bill A3797, commonly referred to as 'CJ's Law,' seeks to criminalize the manufacture, sale, and possession of substances containing kratom, a plant-derived substance known for its psychoactive effects. The bill proposes to classify kratom as a controlled dangerous substance under New Jersey law, addressing growing concerns over its safety and potential for abuse. Kratom has been marketed online for its supposed pain relief and addiction treatment properties. However, it has raised significant alarm due to the risks associated with its use, including addiction and severe health consequences as identified by the FDA.
Contention
The bill was named in memory of Christopher James Holowach, who died from heart complications linked to kratom usage. Supporters claim that the bill is a necessary public health measure to prevent further tragedies similar to Holowach’s death. Critics, however, may argue that the bill could unnecessarily criminalize the use of kratom without sufficient scientific consensus on its effects. Moreover, by restricting access to kratom, which some users consider helpful for pain relief, the bill may provoke debate about the balance between public health and individual freedom in choosing alternative substances for self-medication.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25